Li Wei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Li Wei has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Chaoyu Zhu
Department of Endocrinology, Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publicationsQianqian Wang
Department of Endocrinology, Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publicationsXinyi Wang
Department of Endocrinology, Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publicationsYuanyuan Xiao
Department of Endocrinology, Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publicationsFusong Jiang
Department of Endocrinology, Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication- Jun Yin
Department of Endocrinology and Metabolism, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai, China
1 shared publication
Latest Publications
- Open Access
- 16 April 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Low serum dehydroepiandrosterone sulfate is related to diabetic retinopathy in males with type 2 diabetes mellitus
Objective: Androgens are increasingly recognized as important regulators of metabolic balance and vascular integrity. However, their relationship with diabetic retinopathy (DR) remains incompletely defined and appears to differ by sex. The present study aimed to examine the associations between circulating levels of total testosterone (TT), dehydroepiandrosterone sulfate (DHEAS), and androstenedione (ASD) and DR risk among individuals with type 2 diabetes mellitus (T2DM), with particular emphasis on gender-stratified analyses. Methods: This cross-sectional investigation analyzed 796 hospitalized T2DM cases. Serum concentrations of TT, DHEAS, and ASD were quantified using chemiluminescence immunoassays. Multivariable logistic regression was utilized to assess the associations between androgen levels and the presence of DR, with analyses conducted separately for men and women to account for sex-specific differences. Results: Among male participants, after comprehensive adjustment for potential confounding variables, serum DHEAS levels were independently and inversely linked with DR risk (tertile 3 vs. tertile 1: OR = 0.43, 95% CI: 0.23–0.82; P for trend = 0.007). Restricted cubic spline modeling demonstrated an approximately linear inverse dose-response relationship between DHEAS concentrations and DR risk (overall P < 0.001; nonlinear P = 0.193). No correlations were found between serum TT or ASD levels and DR in men. In female patients, an inverse relationship between TT and DR was attenuated and rendered nonsignificant after full multivariable adjustment, and neither DHEAS nor ASD showed a statistically significant association with DR risk. Conclusions: Lower serum DHEAS concentrations are independently linked with elevated DR risk in males with T2DM, suggesting a potential role for DHEAS in the pathophysiology of DR in males.
- 16 April 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Open AccessLow serum dehydroepiandrosterone sulfate is related to diabetic retinopathy in males with type 2 diabetes mellitus
Objective: Androgens are increasingly recognized as important regulators of metabolic balance and vascular integrity. However, their relationship with diabetic retinopathy (DR) remains incompletely defined and appears to differ by sex. The present study aimed to examine the associations between circulating levels of total testosterone (TT), dehydroepiandrosterone sulfate (DHEAS), and androstenedione (ASD) and DR risk among individuals with type 2 diabetes mellitus (T2DM), with particular emphasis on gender-stratified analyses. Methods: This cross-sectional investigation analyzed 796 hospitalized T2DM cases. Serum concentrations of TT, DHEAS, and ASD were quantified using chemiluminescence immunoassays. Multivariable logistic regression was utilized to assess the associations between androgen levels and the presence of DR, with analyses conducted separately for men and women to account for sex-specific differences. Results: Among male participants, after comprehensive adjustment for potential confounding variables, serum DHEAS levels were independently and inversely linked with DR risk (tertile 3 vs. tertile 1: OR = 0.43, 95% CI: 0.23–0.82; P for trend = 0.007). Restricted cubic spline modeling demonstrated an approximately linear inverse dose-response relationship between DHEAS concentrations and DR risk (overall P < 0.001; nonlinear P = 0.193). No correlations were found between serum TT or ASD levels and DR in men. In female patients, an inverse relationship between TT and DR was attenuated and rendered nonsignificant after full multivariable adjustment, and neither DHEAS nor ASD showed a statistically significant association with DR risk. Conclusions: Lower serum DHEAS concentrations are independently linked with elevated DR risk in males with T2DM, suggesting a potential role for DHEAS in the pathophysiology of DR in males.
- 1 January 2026
- Published by e-Century Publishing Corporation in American Journal of Translational Research
- Vol. 18 (5) , 4248-4264
Single-nucleus transcriptomics identifies SPON1 as a candidate mediator of the anti-fibrotic effect of Abelmoschus manihot (L.) in diabetic kidney disease
Objectives: This study elucidated the cell-type-specific mechanisms and molecular targets underlying the anti-fibrotic effects of Abelmoschus manihot (AM) extract in diabetic kidney disease (DKD). We focused on identifying fibrosis-associated regulators using single-nucleus RNA sequencing (snRNA-seq) and validating them experimentally. Methods: DKD was induced in C57BL/6J mice by a high-fat diet and streptozotocin. Mice received oral AM extract (2.0 g/kg/day) for 14 weeks. We performed snRNA-seq on control, DKD, and AM-treated kidneys, utilizing computational tools to infer intercellular communication. Validation was conducted using quantitative real-time polymerase chain reaction (qRT-PCR), immunohistochemistry, western blotting, and confocal microscopy. In vitro, human renal proximal tubular epithelial (HK-2) cells were exposed to high glucose (HG) with or without AM treatment. Results: AM significantly reduced the urinary albumin-to-creatinine ratio and ameliorated glomerular and interstitial fibrosis in DKD mice. snRNA-seq identified proximal tubular segment 1 and interstitial cell clusters as the primary responders to AM. The extract suppressed transforming growth factor-beta TGF-β/Smad-related profibrotic signaling and remodeled epithelial-stromal intercellular communication by downregulating C-X-C motif chemokine ligand (CXCL) and colony-stimulating factor (CSF) pathways. Notably, spondin 1 (SPON1), an extracellular matrix-associated matricellular protein, was among the most significantly downregulated genes. Consistent with these findings, SPON1 expression was markedly reduced in both DKD kidneys and HG-injured HK-2 cells following AM administration. Conclusions: AM attenuates diabetic renal fibrosis by reducing SPON1 expression, suppressing profibrotic signaling, and remodeling epithelial-stromal crosstalk. These findings provide cell-type-resolved insights into AM’s renoprotective mechanisms and highlight SPON1 as a candidate molecular target in DKD.
- 1 January 2026
- Published by e-Century Publishing Corporation in American Journal of Translational Research
- Vol. 18 (5) , 4248-4264
Single-nucleus transcriptomics identifies SPON1 as a candidate mediator of the anti-fibrotic effect of Abelmoschus manihot (L.) in diabetic kidney disease
Objectives: This study elucidated the cell-type-specific mechanisms and molecular targets underlying the anti-fibrotic effects of Abelmoschus manihot (AM) extract in diabetic kidney disease (DKD). We focused on identifying fibrosis-associated regulators using single-nucleus RNA sequencing (snRNA-seq) and validating them experimentally. Methods: DKD was induced in C57BL/6J mice by a high-fat diet and streptozotocin. Mice received oral AM extract (2.0 g/kg/day) for 14 weeks. We performed snRNA-seq on control, DKD, and AM-treated kidneys, utilizing computational tools to infer intercellular communication. Validation was conducted using quantitative real-time polymerase chain reaction (qRT-PCR), immunohistochemistry, western blotting, and confocal microscopy. In vitro, human renal proximal tubular epithelial (HK-2) cells were exposed to high glucose (HG) with or without AM treatment. Results: AM significantly reduced the urinary albumin-to-creatinine ratio and ameliorated glomerular and interstitial fibrosis in DKD mice. snRNA-seq identified proximal tubular segment 1 and interstitial cell clusters as the primary responders to AM. The extract suppressed transforming growth factor-beta TGF-β/Smad-related profibrotic signaling and remodeled epithelial-stromal intercellular communication by downregulating C-X-C motif chemokine ligand (CXCL) and colony-stimulating factor (CSF) pathways. Notably, spondin 1 (SPON1), an extracellular matrix-associated matricellular protein, was among the most significantly downregulated genes. Consistent with these findings, SPON1 expression was markedly reduced in both DKD kidneys and HG-injured HK-2 cells following AM administration. Conclusions: AM attenuates diabetic renal fibrosis by reducing SPON1 expression, suppressing profibrotic signaling, and remodeling epithelial-stromal crosstalk. These findings provide cell-type-resolved insights into AM’s renoprotective mechanisms and highlight SPON1 as a candidate molecular target in DKD.